20/20 BioLabs to host investor webinar on FDA advisory panel vote, OneTest franchise model

Bitget2026/09/29 12:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

20/20 BioLabs will host an investor webinar on Oct. 7, 2026 at 12:00 p.m. ET.
Management plans to discuss the Sept. 23, 2026 FDA advisory committee vote on GRAIL’s Galleri test, read-through for MCED regulation.
Discussion will also cover the OneTest franchise model, early lab interest, state-backed firefighter cancer screening initiatives, followed by Q&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 20/20 Biolabs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290831PRIMZONEFULLFEED9835519) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

20/20 BioLabs to host investor webinar on FDA advisory panel vote, OneTest franchise model

You may also like

Crypto prices